D-0130-2020 Class II Terminated
FDA drug recall D-0130-2020 was initiated by Morton Grove Pharmaceuticals, Inc. on Sep 23, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications - failed specs for Prednisolone Impurity 14 The recall status is terminated (terminated Sep 24, 2022). Affected quantity: 196,408 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 16, 2019
- Initiation Date
- Sep 23, 2019
- Termination Date
- Sep 24, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 196,408 bottles
Product description
Prednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, packaged in a 8 fl oz (237 mL) bottle, Rx only, Manufactured By Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053. NDC 60432-212-08
Reason for recall
Failed Impurities/Degradation Specifications - failed specs for Prednisolone Impurity 14
Distribution pattern
Nationwide USA and Puerto Rico
Code information
Lot #: US1450, Exp 10/31/19; US1570, Exp 12/31/19; UT1018, Exp 1/31/19; UT1173, Exp 6/30/20; UT1348, UT1354, Exp 8/31/20
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0130-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026